The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Healthcare utilization and cost of pneumococcal disease in the United States
Open accessAbstract
BACKGROUND Streptococcus pneumoniae continues to cause a variety of common clinical syndromes, despite vaccination programs for both adults and children. The total U.S. burden of pneumococcal disease is unknown. METHODS We constructed a decision tree-based model to estimate U.S. healthcare utilization and costs of pneumococcal disease in 2004. Data were obtained from the 2004-2005 National (Hospital) Ambulatory Medical Care Surveys (outpatient visits, antibiotics) and the National Hospital Discharge Survey (hospitalization rates), and CDC surveillance data. Other assumptions regarding the incidence of each syndrome due to pneumococcus, expected health outcomes, and healthcare utilization were derived from literature and expert opinion. Healthcare and time costs used 2007 dollars. RESULTS We estimate that, in 2004, pneumococcal disease caused 4.0 million illness episodes, 22,000 deaths, 445,000 hospitalizations, 774,000 emergency department visits, 5.0 million outpatient visits, and 4.1 million outpatient antibiotic prescriptions. Direct medical costs totaled $3.5 billion. Pneumonia (866,000 cases) accounted for 22% of all cases and 72% of pneumococcal costs. In contrast, acute otitis media and sinusitis (1.5 million cases each) comprised 75% of cases but only 16% of direct medical costs. Patients ≥ 65 years old, accounted for most serious cases and the majority of direct medical costs ($1.8 billion in healthcare costs annually). In this age group, pneumonia caused 242,000 hospitalizations, 1.4 million hospital days, 194,000 emergency department visits, 374,000 outpatient visits, and 16,000 deaths. However, if work loss and productivity are considered, the cost of pneumococcal disease among younger working adults (18-<50) nearly equaled those ≥ 65. CONCLUSIONS Pneumococcal disease remains a substantial cause of morbidity and mortality even in the era of routine pediatric and adult vaccination. Continued efforts are warranted to reduce serious pneumococcal disease, especially adult pneumonia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O'Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Mulholland, K., Levine, O. S., & Cherian, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61204-6 · Cited by 2,398
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
Fiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 2,077
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Pilishvili, T., Lexau, C., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Reingold, A., Thomas, A., Schaffner, W., Craig, A. S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/648593 · Cited by 1,311
Self-citationThe Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
Shapiro, E. D., Berg, A. T., Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252101 · Cited by 1,051
Diagnosis and Management of Acute Otitis Media
Media, S. O. M. O. A. O. (2004) · Pediatrics · doi:10.1542/peds.113.5.1451 · Cited by 902
Hicks, L. A., Harrison, L. H., Flannery, B., Hadler, J. L., Schaffner, W., Craig, A. S., Jackson, D., Thomas, A., Beall, B., Lynfield, R., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521626 · Cited by 737
The Diagnosis and Management of Acute Otitis Media
(2021) · Pediatric Clinical Practice Guidelines & Policies, 21st Ed · doi:10.1542/9781610025034-part01-the_diagnosis · Cited by 692
Lexau, C. A. (2005) · JAMA · doi:10.1001/jama.294.16.2043 · Cited by 671
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations
Butler, J. C. (1993) · JAMA · doi:10.1001/jama.270.15.1826 · Cited by 671
Grijalva, C. G., Nuorti, J. P., Arbogast, P. G., Martin, S. W., Edwards, K. M., & Griffin, M. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60564-9 · Cited by 667
Self-citationActive Bacterial Core Surveillance of the Emerging Infections Program Network
Schuchat, A., Hilger, T., Zell, E., Farley, M. M., Reingold, A., Harrison, L., Lefkowitz, L., Danila, R., Stefonek, K., Barrett, N., et al. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010114 · Cited by 592
Self-citationPopulation Snapshot of Emergent Streptococcus pneumoniae Serotype 19A in the United States, 2005
Moore, M. R., Gertz, Jr., Woodbury, R. L., Barkocy‐Gallagher, G. A., Schaffner, W., Lexau, C., Gershman, K., Reingold, A., Farley, M., Harrison, L. H., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/528996 · Cited by 480
Self-citationPoehling, K. A., Talbot, T. R., Griffin, M. R., Craig, A. S., Whitney, C. G., Zell, E., Lexau, C. A., Thomas, A. R., Harrison, L. H., Reingold, A. L., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1668 · Cited by 463
Self-citationContinued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children
Huang, S. S., Hinrichsen, V. L., Stevenson, A. E., Rifas-Shiman, S. L., Kleinman, K., Pelton, S. I., Lipsitch, M., Hanage, W. P., Lee, G. M., & Finkelstein, J. A. (2009) · Pediatrics · doi:10.1542/peds.2008-3099 · Cited by 269
Self-citationGonzales, R., Bartlett, J. G., Besser, R. E., Cooper, R. J., Hickner, J. M., Hoffman, J. R., & Sande, M. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-6-200103200-00013 · Cited by 251
Grijalva, C. G., Poehling, K. A., Nuorti, J. P., Zhu, Y., Martin, S. W., Edwards, K. M., & Griffin, M. R. (2006) · Pediatrics · doi:10.1542/peds.2006-0492 · Cited by 240
Self-citationGoldblatt, D., Southern, J., Andrews, N. J., Ashton, L., Burbidge, P., Woodgate, S., Pebody, R. G., & Miller, E. (2009) · Clinical Infectious Diseases · doi:10.1086/606046 · Cited by 163
Immunological responses to pneumococcal vaccine in frail older people
Ridda, I., MacIntyre, C. R., Lindley, R., Gao, Z., Sullivan, J. S., Yuan, F. F., & McIntyre, P. B. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.11.098 · Cited by 144
Economic Productivity by Age and Sex: 2007 Estimates for the United States
Grosse, S. D., Krueger, K. V., & Mvundura, M. (2009) · Medical Care · doi:10.1097/mlr.0b013e31819c9571 · Cited by 115
Dransfield, M. T., Nahm, M. H., Han, M. K., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0488oc · Cited by 87
Morrow, A., Wals, P. D., Petit, G., Guay, M., & Erickson, L. J. (2006) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2007/713576 · Cited by 81
Greene, C. M., Kyaw, M. H., Ray, S. M., Schaffner, W., Lynfield, R., Barrett, N. L., LONG, C. E., Gershman, K., Pilishvili, T., Roberson, A., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/505117 · Cited by 48
Self-citationEmergence of Antimicrobial-Resistant Serotype 19A Streptococcus pneumoniae—Massachusetts, 2001-2006
(2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.01.007 · Cited by 45
Adults with Invasive Pneumococcal DiseaseMissed Opportunities for Vaccination
Kyaw, M. H., Greene, C. M., Schaffner, W., Ray, S. M., Shapiro, M. C., Barrett, N. L., Gershman, K., Craig, A. S., Roberson, A., Zell, E. R., et al. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.06.007 · Cited by 31
Self-citationLindbæk, K. K. M. M. (2001) · Scandinavian Journal of Primary Health Care · doi:10.1080/028134301750235385 · Cited by 13
Cited by
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Moore, M. R., Link-Gelles, R., Schaffner, W., Lynfield, R., Lexau, C., Bennett, N. M., Petit, S., Zansky, S. M., Harrison, L. H., Reingold, A., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71081-3 · Cited by 733
Self-citationSecondary bacterial infections associated with influenza pandemics
Morris, D. E., Cleary, D. W., & Clarke, S. C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01041 · Cited by 576
Pneumococcal infection in adults: burden of disease
Drijkoningen, J. J. C., & Rohde, G. G. U. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12461 · Cited by 384
Bomar, L., Brugger, S. D., Yost, B. H., Davies, S. S., & Lemon, K. P. (2016) · mBio · doi:10.1128/mbio.01725-15 · Cited by 332
Metadata
- Authors
- Huang, S. S., Johnson, K. M., Ray, G. T., Wroe, P., Lieu, T. A., Moore, M. R., Zell, E. R., Linder, J. A., Grijalva, C. G., Metlay, J. P., & Finkelstein, J. A.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 29
- Issue
- 18
- Pages
- 3398-3412
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2038507666
- Cited by
- 296
- References
- 27
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.